Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
Kono K, Iinuma H, Akutsu Y, Tanaka H, Hayashi N, Uchikado Y, Noguchi T, Fujii H, Okinaka K, Fukushima R, Matsubara H, Ohira M, Baba H, Natsugoe S, Kitano S, Takeda K, Yoshida K, Tsunoda T, Nakamura Y.
Kono K, et al. Among authors: iinuma h.
J Transl Med. 2012 Jul 9;10:141. doi: 10.1186/1479-5876-10-141.
J Transl Med. 2012.
PMID: 22776426
Free PMC article.
Clinical Trial.